Showing results (351-360 of 1,755) with videos related to
Sort By:
Pageof 176
Experimental and Clinical Psychopharmacology|October 7, 2021
Feasibility, tolerability, and potential advantages of a dyadic financial incentive treatment for smoking cessation among dual-smoker couples: A pilot studyLeeAnn B Haskins, Christiana A Payne, William M Schiavone, et al.Experimental and Clinical Psychopharmacology|January 27, 2022
Ethanol induces a dose-dependent conditioned place preference and conditioned place aversion in Japanese quailShannon E Eaton, Svetlana Dzhala, Layne E Robinson, et al.Experimental and Clinical Psychopharmacology|February 3, 2022
Posttraumatic stress as a moderator of the association between HPA-axis functioning and alcohol use disorder among a community sample of women currently experiencing intimate partner violenceSilvi C Goldstein, Melissa R Schick, Lisa L Weyandt, et al.Experimental and Clinical Psychopharmacology|April 25, 2022
Changes in secondary substance use after the onset of the COVID-19 pandemic among people who use cannabis: Findings from a web-based sample of adults in the United StatesStephanie Lake, Ryan D Assaf, Pamina M Gorbach, et al.Experimental and Clinical Psychopharmacology|April 25, 2022
A crowdsourcing survey study on the subjective effects of delta-8-tetrahydrocannabinol relative to delta-9-tetrahydrocannabinol and cannabidiolCecilia L Bergeria, Justin C Strickland, Tory R Spindle, et al.Experimental and Clinical Psychopharmacology|May 24, 2019
Using a dependent schedule to measure risky choice in male rats: Effects of d-amphetamine, methylphenidate, and methamphetamineJustin R Yates, Nicholas A Prior, Marissa R Chitwood, et al.Experimental and Clinical Psychopharmacology|May 24, 2019
The use of cannabinoids for sleep: A critical review on clinical trialsNirushi Kuhathasan, Alexander Dufort, James MacKillop, et al.Experimental and Clinical Psychopharmacology|May 24, 2019
Age-related differences in Δ⁹-tetrahydrocannabinol-induced antinociception in female and male ratsRebecca M Craft, Stevie C Britch, Nate W Buzitis, et al.Experimental and Clinical Psychopharmacology|May 24, 2019
Real-world clinical characterization of subjects with depression treated with antidepressant drugs focused on (non-)genetic factors, pharmacokinetics, and clinical outcomes: GnG-PK/PD-AD studyPaulo Magalhães, Gilberto Alves, Ana Fortuna, et al.Experimental and Clinical Psychopharmacology|June 21, 2019
Acute behavioral tolerance to alcoholR Edward Comley, Matthew J DryPageof 176